PerpEquities

Equity · Financial services

Is Travelers Companies (The) (TRV) tradable as a perp? Not yet

The Travelers Companies provides commercial and personal property and casualty insurance, including auto, homeowners, workers' comp, and surety bonds.

Not yet listed on any perp exchange

No perpetual-futures venue lists TRV yet. We track it continuously; as soon as the first listing appears, this page becomes a full market page. Until then: fundamentals below and tradable alternatives.

Similar stocks already tradable as perps

Price chart

Interactive TradingView chart

TradingView symbol NYSE:TRV

Loads TradingView's third-party widget (about 1 MB) on demand.

Auto: underlying reference priceOpen in TradingView

Company financials

Financials at a glance

Last report Q3 '26 · filed 2026-10-16 · next report 2027-01-20 · Updated 387h ago
All financials →

Valuation & key figures

Market cap
$80.4B
Updated 387h ago
Revenue
$48.9B
Trailing 12 months
Revenue growth
-10%
Next fiscal year
Profit margin
+17.0%
P/E
9.9
Peer P/E 14.5
P/S
1.6
Peer P/E
14.5
Similar listed perps
Free cash flow
$10.7B
Trailing 12 months
Net income
$8.3B
Trailing 12 months
Revenue estimate
$44B
Next fiscal year
Earnings
2027-01-20
Revenue est. $10.8B · Updated 387h ago
Dividend
$1.25
2026-12-10
Revenue (TTM)$48.9B+1.1% vs a year agoLast 4 quarters; bars = each quarter
Operating margin (TTM)21.6%+6.6 pp vs a year agoOperating income $10.6B
Net income (TTM)$8.33B+41.8% vs a year agoAfter tax, incl. non-operating gains
Free cash flow (TTM)$10.7B+6.9% vs a year agoCapex $0
Diluted EPS (TTM)$38.14+50.0% vs a year agoSum of the last 4 quarters
Net cash$86.5B-3.8% vs a year agoCash + short-term investments - debt
  • Last report (2026-10-16): revenue beat by 9.2%, EPS beat by 24.2%Revenue $12.4B vs $11.4B expected (+9.2%); EPS $9.18 vs $7.39 (+24.2%).
  • Revenue growth slowing: -0.5% year on yearQ3 '26 revenue $12.4B, against an average of 2.4% over the four quarters before.
  • Operating margin 21.6% (TTM), +6.6 pp on a year agoOperating income grew 45.3% while revenue grew 1.1%.
  • Capex 0.0% of revenue (a year ago 0.0%)$0 invested in the last 4 quarters (– on a year earlier). Free cash flow $10.7B = 128.1% of net income.

Revenue, operating income and growth

quarterly

Revenue by business line

latest quarter
LineRevenuey/yShare
Business Insurance$6.84B+2.8%55.0%
Personal Insurance$4.37B-5.5%35.1%
Bond & Specialty Insurance$1.24B+6.0%9.9%
In the full financialsIncome statement, balance sheet and cash flow (12 quarters / 10 years) · margins and cost structure · capital allocation and buybacks · valuation against the 5-year range · analyst estimates · all 296 lines The Travelers Companies, Inc. reported to the SEC

Research data

Analysts, filings and peer context

Estimates

6
DateEPS estimateRevenue estimateGrowthAnalysts
FY 202635.66$44B-10%15
FY 202730.75$45.1B-8%17
FY 202831.31$46.5B-5%8
Q1 20277.83$10.6B-11%14
Q2 20275.88$11.7B-4%6
Q3 20276.96$11.6B-6%6

Company events

6
2027-01-20EarningsActual - / Estimate 9.73-
2026-12-10Dividend$1.25-
2026-10-16Earnings · Before market openActual 9.18 / Estimate 7.39Beat
2026-09-10Dividend$1.25-
2026-07-17EarningsActual 10.04 / Estimate 5.41Beat
2026-06-10Dividend$1.25-

Peer comparison

Similar listed perps

Analyst track record

How the analysts covering TRV have done: ratings, price-target accuracy and the measured reaction after their calls.

12 months3 years
Ratings131342
Analysts2533
Buy / hold / sell39 / 64 / 28112 / 167 / 63
Upgrades / downgrades / initiations1 / 9 / 26 / 17 / 11
Price targets hit / missed114 / 8 (93%)310 / 8 (97%)
Avg. return after a rating (TipRanks)+19.6%+43.7%
Best / worst call+62.6% / -13.4%+131.6% / -13.4%

After buy calls on this stock: median 21-day move +3.9% vs S&P 500 +0.5% (n = 108)

Most accurate on this stock

Share of an analyst's price targets on this stock that the price reached within 12 months (our measurement over the last 3 years, at least 8 targets). It describes past calls, not the odds of the current one.

  1. David MotemadenEvercore ISI100% hit rate on this stock · 11 targets measuredHoldtarget $342Sep 21, 2026
  2. Jimmy BhullarJ.P. Morgan100% hit rate on this stock · 9 targets measuredHoldtarget $379Oct 20, 2026
  3. Meyer ShieldsKBW100% hit rate on this stock · 8 targets measuredHoldtarget $382Oct 19, 2026

Latest ratings

DateAnalystCallTarget
Oct 26, 2026Harry FongRoth MKMBuyMaintained$460
Oct 26, 2026Harry FongRoth MKMBuyMaintained$460
Oct 23, 2026Ryan TunisCantor FitzgeraldBuyReiterated$397
Oct 23, 2026Bob HuangMorgan StanleySellReiterated$350
Oct 20, 2026Bob HuangMorgan StanleySellReiterated$330
Consensus over the last 12 months buy hold sell avg. target month-end close
Monthly buy, hold and sell shares of analyst ratings with the average price target and the month-end close$280$300$320$340$360$380$400Dec 25 · Buy 8 · Hold 10 · Sell 2Dec 25Jan 26 · Buy 8 · Hold 9 · Sell 2Feb 26 · Buy 8 · Hold 9 · Sell 2Feb 26Mar 26 · Buy 8 · Hold 8 · Sell 3Apr 26 · Buy 7 · Hold 8 · Sell 3Apr 26May 26 · Buy 7 · Hold 9 · Sell 2Jun 26 · Buy 7 · Hold 8 · Sell 3Jun 26Jul 26 · Buy 6 · Hold 11 · Sell 6Aug 26 · Buy 6 · Hold 11 · Sell 6Aug 26Sep 26 · Buy 6 · Hold 11 · Sell 6Oct 26 · Buy 5 · Hold 13 · Sell 6Oct 26Nov 26 · Buy 5 · Hold 13 · Sell 6Dec 25 · avg. target $300Jan 26 · avg. target $302Feb 26 · avg. target $304Mar 26 · avg. target $306Apr 26 · avg. target $314May 26 · avg. target $316Jun 26 · avg. target $313Jul 26 · avg. target $351Aug 26 · avg. target $351Sep 26 · avg. target $355Oct 26 · avg. target $374Nov 26 · avg. target $374Dec 25 · month-end close $290Jan 26 · month-end close $285Feb 26 · month-end close $309Mar 26 · month-end close $292Apr 26 · month-end close $305May 26 · month-end close $292Jun 26 · month-end close $330Jul 26 · month-end close $374Aug 26 · month-end close $366Sep 26 · month-end close $357Oct 26 · month-end close $396Nov 26 · month-end close $396

Share of analysts per call each month (latest call per analyst within 180 days). Targets and closes in USD.

TipRanks data · computed Oct 30, 2026 · 131 ratings